Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens.

Autor: Yildiz R, Buyukberber S, Uner A, Yamac D, Coskun U, Kaya AO, Ozturk B, Yaman E, Benekli M, Yildiz, Ramazan, Buyukberber, Suleyman, Uner, Aytug, Yamac, Deniz, Coskun, Ugur, Kaya, Ali Osman, Ozturk, Banu, Yaman, Emel, Benekli, Mustafa

Publikováno v: Cancer Investigation; Feb2010, Vol. 28 Issue 1, p33-37, 5p

Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.

Autor: Yildiz R, Coskun U, Kaya AO, Ozturk B, Yaman E

Publikováno v: Annals of Pharmacotherapy; May2007, Vol. 41 Issue 5, p901-902, 2p

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study.

Autor: Kutlu Y; Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34083, Turkey., Dae SA; Department of Medical Oncology, Faculty of Medicine, Baskent University, Adana 01140, Turkey., Yilmaz F; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara 06800, Turkey., Erdem D; Department of Medical Oncology, VM Medical Park Samsun Hospital, Samsun 55200, Turkey., Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey., Akbas S; Department of Medical Oncology, Faculty of Medicine, Koc University, Istanbul 34460, Turkey., Senocak Tasci E; Department of Medical Oncology, Acibadem Atakent Hospital, Istanbul 34303, Turkey., Bas O; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara 06800, Turkey., Dane F; Department of Medical Oncology, Acibadem Altunizade Hospital, Istanbul 34662, Turkey., Sakin A; Department of Medical Oncology, Medipol University Bahcelievler Hospital, Istanbul 34196, Turkey., Kaya AO; Department of Medical Oncology, Medicana International Hospital, Istanbul 34520, Turkey., Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara 06010, Turkey., Ergun Y; Department of Medical Oncology, Antalya City Hospital, Antalya 07200, Turkey., Biter S; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana 01330, Turkey., Disel U; Department of Medical Oncology, Acibadem Adana Hospital, Adana 01130, Turkey., Korkmaz M; Department of Medical Oncology, Tokat State Hospital, Tokat 60100, Turkey., Selcukbiricik F; Department of Medical Oncology, Faculty of Medicine, Koc University, Istanbul 34460, Turkey., Kose F; Department of Medical Oncology, Faculty of Medicine, Baskent University, Adana 01140, Turkey., Olmez OF; Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34083, Turkey., Bilici A; Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34083, Turkey., Demir G; Department of Medical Oncology, Acibadem Maslak Hospital, Istanbul 34398, Turkey., Yalcin S; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara 06800, Turkey.

Publikováno v: Cancers [Cancers (Basel)] 2024 Jun 18; Vol. 16 (12). Date of Electronic Publication: 2024 Jun 18.

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.

Autor: Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey., Sendur MAN; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey., Bilgetekin I; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Garbioglu DB; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey., Hamdard J; Department of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Akbas S; Department of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Hizal M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Arslan C; Department of Medical Oncology, Izmir Medical Park Hospital, Izmir, Turkey., Sevinc A; Department of Medical Oncology, Gaziantep Medical Park Hospital, Edirne, Turkey., Kucukarda A; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Erdem D; Department of Medical Oncology, Samsun Medical Park Hospital, Samsun, Turkey., Kahraman S; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Cakir E; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Demirkiran A; Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir, Turkey., On S; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey., Dogan I; Department of Medical Oncology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey., Erdogan AP; Department of Medical Oncology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey., Koca S; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Kubilay P; Department of Medical Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey., Eren OO; Department of Medical Oncology, Diskapi Training and Research Hospital, Ankara, Turkey., Cilbir E; Department of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey., Celik E; Department of Medical Oncology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey., Araz M; Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir, Turkey., Ozyukseler DT; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey., Yildirim ME; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey., Bahceci A; Department of Medical Oncology, Dr. Ersin Arslan Education and Research Hospital, Gaziantep, Turkey., Taskaynatan H; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey., Oyman A; Department of Medical Oncology, Umraniye Education and Research Hospital, Istanbul, Turkey., Deniz GI; Department of Medical Oncology, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey., Menekse S; Department of Medical Oncology Manisa City Hospital, Manisa, Turkey., Kut E; Department of Medical Oncology Manisa City Hospital, Manisa, Turkey., Gulmez A; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey., Sakin A; Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey., Nayir E; Department of Medical Oncology, Mersin Medical Park Hospital, Mersin, Turkey., Acar R; Department of Medical Oncology, Gulhane Education and Research Hospital, Ankara, Turkey., Sen E; Department of Medical Oncology, Mehmet Akif Ersoy Hospital, Canakkale, Turkey., Inal A; Department of Medical Oncology, Mersin City Hospital, Mersin, Turkey., Turhal S; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Kaya AO; Department of Medical Oncology, Faculty of Medicine, Biruni University, Istanbul, Turkey., Paydas S; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey., Tastekin D; Department of Medical Oncology, Istanbul University, Institute of Oncology, Istanbul, Turkey., Hacibekiroglu I; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Cincin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey., Bilici A; Department of Medical Oncology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Mandel NM; Department of Medical Oncology, Istanbul American Hospital, Istanbul, Turkey., Dede DS; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey., Akinci MB; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey., Oksuzoglu B; Department of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, 5Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Uncu D; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Yalcin B; Department of Medical Oncology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey., Artac M; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Dec; Vol. 18 (12 Suppl 2), pp. S347-S353.

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.

Autor: Tural D; Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Zuhuratbaba District, Tevfik Saglam St. No: 11, Bakirkoy, Istanbul, Turkey. deniztural@gmail.com., Ölmez ÖF; Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Sümbül AT; Medical Oncology, Baskent University Medical Faculty, Adana, Turkey., Özhan N; Medical Oncology, Pamukkale University Medical Faculty, Denizli, Turkey., Çakar B; Medical Oncology, Ege University Medical Faculty, Izmir, Turkey., Köstek O; Medical Oncology, Trakya University Medical Faculty, Edirne, Turkey., Ekenel M; Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey., Erman M; Medical Oncology, Hacettepe University Medical Faculty, Ankara, Turkey., Coşkun HŞ; Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey., Selçukbiricik F; Medical Oncology, Koc University Medical Faculty, Istanbul, Turkey., Keskin Ö; Medical Oncology, Selcuk University Medical Faculty, Konya, Turkey., Türköz FP; Istinye Universty, MedicalPark Goztepe Hospital, Istanbul, Turkey., Oruç K; Medical Oncology, Istanbul University-Cerrahpasa Medical Faculty, Istanbul, Turkey., Bayram S; Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Bilgetekin İ; Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Yıldız B; Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Şendur MAN; Medical Oncology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey., Paksoy N; Medical Oncology, Hacettepe University Medical Faculty, Ankara, Turkey., Dirican A; Medical Oncology, Celal Bayar University Medical Faculty, Manisa, Turkey., Erdem D; Medical Oncology, Medical Park Samsun Hospital, Samsun, Turkey., Selam M; Medical Oncology, Liv Hospital, Istanbul, Turkey., Tanrıverdi Ö; Medical Oncology, Sitki Kocman University Medical Faculty, Mugla, Turkey., Paydaş S; Medical Oncology, Cukurova University Medical Faculty, Adana, Turkey., Urakçı Z; Medical Oncology, Dicle University Medical Faculty, Diyarbakir, Turkey., Atağ E; Medical Oncology, Dokuz Eylul University Medical Faculty, Izmir, Turkey., Güncan S; Medical Oncology, Mersin University Medical Faculty, Mersin, Turkey., Ürün Y; Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey., Alkan A; Medical Oncology, Osmaniye State Hospital, Osmaniye, Turkey., Kaya AO; Medical Oncology, Medicana Hospital, Istanbul, Turkey., Özyükseler DT; Medical Oncology, Istanbul Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey., Taşkaynatan H; Medical Oncology, Katip Celebi University Atatürk Training and Research Hospital, Izmir, Turkey., Yıldırım M; Medical Oncology, Medical Park Gaziantep Hospital, Gaziantep, Turkey., Sönmez M; Medical Oncology, Ordu State Hospital, Ordu, Turkey., Başoğlu T; Medical Oncology, Marmara University Medical Faculty, Istanbul, Turkey., Gündüz Ş; Medical Oncology, Antalya Memorial Hospital, Antalya, Turkey., Kılıçkap S; Medical Oncology, Istinye University Medical Faculty, Liv Hospital, Ankara, Turkey., Artaç M; Medical Oncology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.

Publikováno v: International journal of clinical oncology [Int J Clin Oncol] 2021 Aug; Vol. 26 (8), pp. 1506-1513. Date of Electronic Publication: 2021 May 23.